Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SALVOVAR: Dose-dense Chemotherapy in Poor Prognostic Ovarian Cancer
NCT06476184Phase 3Recruiting
- Sponsor
- ARCAGY
- Start
- Jul 2024
- Primary completion
- Jun 2027
- Modality
- DNA Intercalators/Alkylators
- Countries
- 4
01
Overview
A Phase 3 trial of carboplatin, Paclitaxel Micelles for Injection in ovarian cancer, sponsored by ARCAGY. Started Jul 2024; status: recruiting.
02
Drugs
carboplatinPaclitaxel Micelles for Injection
03
Conditions
ovarian cancer
Beyond the preview
Go deeper on NCT06476184.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06476184.